Codex DNA OverviewCodex DNA EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DNAY.
Quarterly EBIT
-$5.48M
↑ 45.88% YoY
As of Sep 30, 2024
Annual EBIT (TTM)
-$35.06M
↑ 26.19% YoY
Trailing 12 months ending Sep 30, 2024
Codex DNA OverviewEBIT (Earnings Before Interest and Taxes) analysis for DNAY.
As of Sep 30, 2024
Trailing 12 months ending Sep 30, 2024